Risk of hypomagnesaemia with proton pump inhibitors

被引：0
|
作者：
不详
机构：
来源：
AUSTRALIAN PRESCRIBER | 2011年 / 34卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A recent international safety advisory has warned of a potential association between prolonged use of proton pump inhibitors (PPIs) and serious hypomagnesaemia-related adverse events such as tetany, seizures, delirium and cardiac arrhythmias. While this occurs rarely, prescribers should be vigilant to PPI-associated hypomagnesaemia. Patients presenting with hypomagnesaemia may require PPI discontinuation.
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [41] Proton Pump Inhibitors and Risk of Bone Fractures
    Grigorios I. Leontiadis
    Paul Moayyedi
    Current Treatment Options in Gastroenterology, 2014, 12 (4) : 414 - 423
  • [42] PROTON PUMP INHIBITORS THERAPY AND THE RISK OF PNEUMONIA
    Hsieh, Ronan W.
    Wang, Chih-Hung
    Li, Cheng-Han
    Fan, Cheng-Yi
    Hsu, Tze-Chun
    Chang, Wei-Che
    Hsu, Wan-Ting
    Lee, Chien-Chang
    GASTROENTEROLOGY, 2019, 156 (06) : S304 - S304
  • [43] Calcium, proton pump inhibitors, and fracture risk
    Sugiyama, T.
    Torio, T.
    Miyajima, T.
    Kim, Y. T.
    Oda, H.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 349 - 350
  • [44] Risk of Gynecomastia with Users of Proton Pump Inhibitors
    He, Bonnie
    Carleton, Bruce
    Etminan, Mahyar
    PHARMACOTHERAPY, 2019, 39 (05): : 614 - 618
  • [45] Proton pump inhibitors and the risk of colorectal cancer
    van Soest, Eva M.
    van Rossum, Leo G. M.
    Dieleman, Jeanne P.
    van Oijen, Martijn G. H.
    Siersema, Peter D.
    Sturkenboom, Miriam C. J. M.
    Kuipers, Ernst J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (04): : 966 - 973
  • [46] PROTON PUMP INHIBITORS: A RISK FACTOR FOR OSTEOPOROSIS?
    Criveanu, C.
    Ciurea, P. L.
    Vreju, A. F.
    Musetescu, A. E.
    Barbulescu, A.
    Dinescu, S. C.
    Firulescu, C. S.
    Predescu, O. R.
    Rosu, A.
    Palici, C. F.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S719 - S719
  • [47] Proton pump inhibitors and the risk of colorectal cancer
    Kawada, Tomoyuki
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (05)
  • [48] Proton pump inhibitors and the risk of pancreatic cancer
    Shih-Wei Lai
    Journal of Gastroenterology, 2021, 56 : 293 - 294
  • [49] 'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?
    Atkinson, Nathan S. S.
    Reynolds, D. John M.
    Travis, Simon P. L.
    INTESTINAL RESEARCH, 2015, 13 (03) : 227 - 232
  • [50] HYPOMAGNESAEMIA, HYPOCALCAEMIA AND HYPOKALAEMIA ASSOCIATED WITH PROTON PUMP INHIBITOR THERAPY
    Choy, Kay Hau
    NEPHROLOGY, 2021, 26 : 52 - 52
12345